Find Sodium Tungstate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 13472-45-2, Disodium tungstate, Sodium wolframate, Sodium tungstate(vi), Disodium dioxido(dioxo)tungsten, Tungstate, sodium
Molecular Formula
Na2O4W
Molecular Weight
293.82  g/mol
InChI Key
XMVONEAAOPAGAO-UHFFFAOYSA-N
FDA UNII
64LRH4405G

Sodium Tungstate
1 2D Structure

Sodium Tungstate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
disodium;dioxido(dioxo)tungsten
2.1.2 InChI
InChI=1S/2Na.4O.W/q2*+1;;;2*-1;
2.1.3 InChI Key
XMVONEAAOPAGAO-UHFFFAOYSA-N
2.1.4 Canonical SMILES
[O-][W](=O)(=O)[O-].[Na+].[Na+]
2.2 Other Identifiers
2.2.1 UNII
64LRH4405G
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Sodium Tungstate Dihydrate

2. Sodium Tungstate(vi)

3. Sodium Tungstate(vi) Dihydrate

4. Sodium Tungstate(vi), 181w-labeled

2.3.2 Depositor-Supplied Synonyms

1. 13472-45-2

2. Disodium Tungstate

3. Sodium Wolframate

4. Sodium Tungstate(vi)

5. Disodium Dioxido(dioxo)tungsten

6. Tungstate, Sodium

7. Sodium Tungsten Oxide (na2wo4)

8. Tungstic Acid (h2wo4), Disodium Salt

9. Tungstic Acid, Disodium Salt

10. Disodium;dioxido(dioxo)tungsten

11. Tungstate (wo42-), Disodium, (t-4)-

12. 126752-51-0

13. 64lrh4405g

14. Disodium Wolframate

15. Sodium Tungstate (na2wo4)

16. Disodium Tungstate (na2wo4)

17. Ccris 5814

18. Sodium Tungstate (na2(wo4))

19. Disodium Tetraoxatungstate (2-)

20. Disodium Tetraoxotungstate (2-)

21. Hsdb 5057

22. Sodium Tungstate(vi) (na2wo4)

23. Einecs 236-743-4

24. Unii-64lrh4405g

25. Sodiumtungstate(vi)

26. Sodium Tungstate (vi)

27. Na2wo4

28. Disodium Tetraoxotungstate

29. Tungstate (w10o324-), Sodium (1:4)

30. Tungstate (wo42-), Disodium, (beta-4)-

31. Tungastate (wo4(2-)), Disodium, (t-4)-

32. Ec 236-743-4

33. Sodium Tetraoxotungstate(vi)

34. Disodium Tetraoxatungstate(2-)

35. Disodium Tetraoxotungstate(2-)

36. Chebi:63940

37. Sodium Tungstate(vi) [mi]

38. Akos030227979

39. Gs-3112

40. Ns00093533

41. Q418410

42. Tungstate (wo42-), Sodium (1:2), (t-4)-

43. Tungsten(4+) Ion Disodium Dihydroxide Dioxidandiide

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 293.82 g/mol
Molecular Formula Na2O4W
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count4
Rotatable Bond Count0
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area80.3
Heavy Atom Count7
Formal Charge0
Complexity62.2
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3
4 Drug and Medication Information
4.1 Minimum/Potential Fatal Human Dose

3. 3= MODERATELY TOXIC: PROBABLE ORAL LETHAL DOSE (HUMAN) IS 0.5-5 G/KG, BETWEEN 1 OUNCE & 1 PINT (OR 1 POUND) FOR 70 KG PERSON (150 LB). /TUNGSTEN & ITS SALTS/

Gosselin, R.E., H.C. Hodge, R.P. Smith, and M.N. Gleason. Clinical Toxicology of Commercial Products. 4th ed. Baltimore: Williams and Wilkins, 1976., p. II-102


5 Pharmacology and Biochemistry
5.1 Absorption, Distribution and Excretion

RATS...FED...100 DAYS ON DIETS /INCL SODIUM TUNGSTATE/... PRINCIPAL SITES OF DEPOSITION WERE BONE & SPLEEN WITH TRACE QUANTITIES (LESS THAN 1.0 MG %...) IN KIDNEY & LIVER, & IN SOME ANIMALS IN BLOOD, LUNG, MUSCLE & TESTES.

Friberg, L., G.R. Nordberg, and V.B. Vouk. Handbook on the Toxicology of Metals. New York: Elsevier North Holland, 1979., p. 640


...AFTER ORAL ADMIN OF SODIUM TUNGSTATE...AFTER 1 DAY, GREATEST CONCN IN SPLEEN FOLLOWED BY KIDNEY, PELT, BONE & LIVER. ...FOLLOWING ADMIN...BY GASTRIC INTUBATION IN RATS...HIGHEST CONCN IN KIDNEY FOLLOWED BY BONE & SPLEEN.

Friberg, L., G.R. Nordberg, and V.B. Vouk. Handbook on the Toxicology of Metals. New York: Elsevier North Holland, 1979., p. 640


ALMOST 1/2 OF INGESTED DOSE...OF A SOL SALT...RAPIDLY ABSORBED IN...ANIMAL MODELS... MOST OF ABSORBED TUNGSTEN...RAPIDLY EXCRETED IN URINE. SMALL AMT... RETAINED WAS TRANSFERRED IN PART FROM PLASMA TO RED BLOOD CELLS & DISTRIBUTED MAINLY TO SPLEEN, KIDNEY, & BONE. /SOL W SALT/

Friberg, L., G.R. Nordberg, and V.B. Vouk. Handbook on the Toxicology of Metals. New York: Elsevier North Holland, 1979., p. 637


FOLLOWING IV ADMIN (181)W SODIUM TUNGSTATE IN 2 BEAGLE DOGS, MOST OF ACTIVITY WAS FOUND IN PLASMA DURING 1ST 24 HR, WITH AVG PLASMA TO RED CELL RATIO 3:1, SUGGESTING BINDING OF TUNGSTEN TO CELL SURFACE RATHER THAN PENETRATION OF CELL MEMBRANE. ...SUGGESTED THAT W INCORPORATION INTO RED CELLS OCCURS @ SITES OF HEMATOPOIESIS.

Friberg, L., G.R. Nordberg, and V.B. Vouk. Handbook on the Toxicology of Metals. New York: Elsevier North Holland, 1979., p. 641


For more Absorption, Distribution and Excretion (Complete) data for SODIUM TUNGSTATE (8 total), please visit the HSDB record page.


ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty